Noveris Health Sciences PEG Ratio

Noveris Health Sciences (MYCOF) currently reports a PEG ratio of 6.65. That is below the sector sector average of 10.05. Use the charts on this page to explore Noveris Health Sciences's PEG ratio history and peer comparisons.

Noveris Health Sciences's PEG ratio of 6.65 is lower than the its sector sector average of 10.05. That is roughly 33.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The PEG ratio is a valuation multiple that relates Noveris Health Sciences's market price to a fundamental measure such as earnings, sales, or book value. At 6.65, MYCOF can look expensive or cheap only in context — versus its own history, growth rate, and sector peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current PEG ratio of 6.65, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 10.05. From there, open related valuation or income-statement pages for Noveris Health Sciences, and consider following MYCOF for alerts when major investors trade the stock.